Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Total Assets history
Currency unavailable · from the balance sheet
No Total Assets data reported for this period type.
Total Assets vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
ORKAOruka Therapeutics, Inc. | Sep 2026 | $1.23B USD | +141.7% | +124.7% |
| Sep 2026 | $1.1B USD | +117.9% | +121.9% | |
| Jun 2026 | $885.54M USD | +23.3% | +39.3% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $560.62M USD | -8.2% | +56.2% |
| Mar 2026 | $329.68M USD | -21.9% | -15.8% | |
| Mar 2026 | $198.72M USD | +0.3% | -14.3% | |
| Mar 2026 | $189.74M USD | +824.9% | -42.7% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €165.63M EUR | — | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — |
| Peer median (excluding ODTX) | — | +23.3% | +39.3% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.